Katrin Friedbichler

684 total citations
13 papers, 412 citations indexed

About

Katrin Friedbichler is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Katrin Friedbichler has authored 13 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Katrin Friedbichler's work include Cytokine Signaling Pathways and Interactions (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Katrin Friedbichler is often cited by papers focused on Cytokine Signaling Pathways and Interactions (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). Katrin Friedbichler collaborates with scholars based in Austria, Germany and France. Katrin Friedbichler's co-authors include Richard Moriggl, Kristina M. Mueller, Madeleine Themanns, Jan‐Wilhelm Kornfeld, Lukas Kenner, Fabrice Gouilleux, Peter Valent, Marc A. Kerenyi, Marco H. Hofmann and Jan Tuckermann and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Katrin Friedbichler

12 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katrin Friedbichler Austria	9	187	158	114	108	65	13	412
Hanjun Qin United States	15	245 1.3×	164 1.0×	229 2.0×	33 0.3×	63 1.0×	36	561
Oksana Moshynska Canada	9	168 0.9×	98 0.6×	98 0.9×	60 0.6×	33 0.5×	13	404
Sumie Hiramatsu Japan	13	100 0.5×	143 0.9×	173 1.5×	23 0.2×	60 0.9×	37	477
Gillian McNab United Kingdom	10	187 1.0×	135 0.9×	235 2.1×	29 0.3×	63 1.0×	11	620
Claire Bléchet France	12	194 1.0×	140 0.9×	36 0.3×	49 0.5×	164 2.5×	27	470
Paraskevi Kotsi Greece	10	428 2.3×	141 0.9×	217 1.9×	27 0.3×	78 1.2×	19	725
Donna Dunn United States	5	170 0.9×	145 0.9×	54 0.5×	36 0.3×	93 1.4×	5	494
Hiroyuki Maeta Japan	11	191 1.0×	146 0.9×	38 0.3×	114 1.1×	96 1.5×	24	419
P Lohse Germany	13	218 1.2×	47 0.3×	80 0.7×	53 0.5×	49 0.8×	25	419
Maria Radanova Bulgaria	12	122 0.7×	45 0.3×	199 1.7×	26 0.2×	63 1.0×	36	424

Countries citing papers authored by Katrin Friedbichler

Since Specialization

Citations

This map shows the geographic impact of Katrin Friedbichler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrin Friedbichler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrin Friedbichler more than expected).

Fields of papers citing papers by Katrin Friedbichler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrin Friedbichler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrin Friedbichler. The network helps show where Katrin Friedbichler may publish in the future.

Co-authorship network of co-authors of Katrin Friedbichler

This figure shows the co-authorship network connecting the top 25 collaborators of Katrin Friedbichler. A scholar is included among the top collaborators of Katrin Friedbichler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrin Friedbichler. Katrin Friedbichler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Weyer-Czernilofsky, Ulrike, Marco H. Hofmann, Katrin Friedbichler, et al.. (2020). Antitumor Activity of the IGF-1/IGF-2–Neutralizing Antibody Xentuzumab (BI 836845) in Combination with Enzalutamide in Prostate Cancer Models. Molecular Cancer Therapeutics. 19(4). 1059–1069. 14 indexed citations

Kaltenecker, Doris, Madeleine Themanns, Kristina M. Mueller, et al.. (2018). STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. Cytokine. 124. 154573–154573. 13 indexed citations

Friedbichler, Katrin, Cédric Boudot, Jérôme Bourgeais, et al.. (2017). STAT5A/5B-specific expansion and transformation of hematopoietic stem cells. Blood Cancer Journal. 7(1). e514–e514. 5 indexed citations

Themanns, Madeleine, Katrin Friedbichler, Sonja M. Kessler, et al.. (2014). Abstract 108: Consequences of hepatic JAK2 deficiency for liver metabolism and hepatocarcinogenesis. Cancer Research. 74(19_Supplement). 108–108.

Friedbichler, Katrin, Marco H. Hofmann, Elínborg Ostermann, et al.. (2013). Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin. Molecular Cancer Therapeutics. 13(2). 399–409. 73 indexed citations

Mueller, Kristina M., Madeleine Themanns, Katrin Friedbichler, et al.. (2012). Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Molecular and Cellular Endocrinology. 361(1-2). 1–11. 66 indexed citations

Adam, Paul J., Katrin Friedbichler, Marco H. Hofmann, et al.. (2012). BI 836845, a fully human IGF ligand neutralizing antibody, to improve the efficacy of rapamycin by blocking rapamycin-induced AKT activation.. Journal of Clinical Oncology. 30(15_suppl). 3092–3092. 4 indexed citations

Friedbichler, Katrin. (2011). Serine phosphorylation of the Stat5a C-terminus is a driving force for transformation. Frontiers in bioscience. 16(1). 3043–3043. 9 indexed citations

Friedbichler, Katrin, Madeleine Themanns, Kristina M. Mueller, et al.. (2011). Growth-hormone–induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer. Hepatology. 55(3). 941–952. 40 indexed citations

10.

Friedbichler, Katrin, Marc A. Kerenyi, Boris Kovačic, et al.. (2010). Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation. Blood. 116(9). 1548–1558. 48 indexed citations

11.

Harir, Noria, Cédric Boudot, Katrin Friedbichler, et al.. (2008). Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade. Blood. 112(6). 2463–2473. 95 indexed citations

12.

Steiner, Hannes, Sonia Godoy‐Tundidor, Ilaria T. Cavarretta, et al.. (2005). Stimulation of growth of prostate cancer cells 22Rv1 through activation of the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Cancer Research. 65. 232–232. 1 indexed citations

13.

Godoy‐Tundidor, Sonia, Ilaria T. Cavarretta, Dietmar Fuchs, et al.. (2005). Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase. The Prostate. 64(2). 209–216. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact